Literature DB >> 17073798

Vascular matrix adhesion and the blood-brain barrier.

G J Del Zoppo1, R Milner, T Mabuchi, S Hung, X Wang, J A Koziol.   

Abstract

The integrity of the cerebral microvasculature depends on the interaction between its component cells and the extracellular matrix, as well as reorganized cell-cell interactions. In the central nervous system, matrix adhesion receptors are expressed in the microvasculature and by neurons and their supporting glial cells. Cells within cerebral microvessels express both the integrin and dystroglycan families of matrix adhesion receptors. However, the functional significance of these receptors is only now being explored. Endothelial cells and astrocytes within cerebral capillaries co-operate to generate and maintain the basal lamina and the unique barrier functions of the endothelium. Integrins and the dystroglycan complex are found on the matrix-proximate faces of both endothelial cells and astrocyte end-feet. Pericytes rest against the basal lamina. In the extravascular compartment, select integrins are expressed on neurons, microglial cells and oligodendroglia. Significant alterations in both cellular adhesion receptors and their matrix ligands occur during focal cerebral ischaemia, which support their functional significance in the normal state. We propose that matrix adhesion receptors are essential for the maintenance of the integrity of the blood-brain permeability barrier and that modulation of these receptors contributes to alterations in the barrier during brain injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073798     DOI: 10.1042/BST0341261

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  33 in total

Review 1.  Neurovascular unit: a focus on pericytes.

Authors:  Inês Sá-Pereira; Dora Brites; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2012-02-28       Impact factor: 5.590

2.  Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury.

Authors:  Ke-Jie Yin; Zhen Deng; Milton Hamblin; Yi Xiang; Huarong Huang; Jifeng Zhang; Xiaodan Jiang; Yanzhuang Wang; Y Eugene Chen
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 3.  Intrinsic axonal degeneration pathways are critical for glaucomatous damage.

Authors:  Gareth R Howell; Ileana Soto; Richard T Libby; Simon W M John
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

4.  Dabigatran abrogates brain endothelial cell permeability in response to thrombin.

Authors:  Brian Thomas Hawkins; Yu-Huan Gu; Yoshikane Izawa; Gregory John del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

Review 5.  The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.

Authors:  Britta Engelhardt; Lydia Sorokin
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

Review 6.  Cellular elements of the blood-brain barrier.

Authors:  Jorge Correale; Andrés Villa
Journal:  Neurochem Res       Date:  2009-10-25       Impact factor: 3.996

Review 7.  Glia unglued: how signals from the extracellular matrix regulate the development of myelinating glia.

Authors:  Holly Colognato; Iva D Tzvetanova
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

Review 8.  The blood-brain barrier.

Authors:  Richard Daneman; Alexandre Prat
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-05       Impact factor: 10.005

Review 9.  Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development.

Authors:  Beatriz Rodriguez-Grande; Aleksandra Ichkova; Sighild Lemarchant; Jerome Badaut
Journal:  AAPS J       Date:  2017-09-13       Impact factor: 4.009

10.  Expression sites of colligin 2 in glioma blood vessels.

Authors:  Dana Mustafa; Marcel van der Weiden; PingPin Zheng; Alex Nigg; Theo M Luider; Johan M Kros
Journal:  Brain Pathol       Date:  2009-12-05       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.